Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study. J of Skin. 2026;10(2):s737. doi:10.25251/0y59xj91